
Sasha Latypova
Former pharmaceutical industry executive turned whistleblower, dedicated to uncovering fraud in the industry and sharing her insights on Substack.
Top 3 podcasts with Sasha Latypova
Ranked by the Snipd community

47 snips
Apr 22, 2025 • 1h 1min
83. The PREP Act: An Act of TREASON | Sasha Latypova & Katherine Watt | The Feds
Sasha Latypova, an independent writer with over 25 years in healthcare technology, joins Katherine Watt, a reporter focused on government accountability. They delve into the controversial PREP Act, arguing its unconstitutional nature and labeling it as treasonous. The discussion extends to how the act influences COVID-19 mandates and public health policies. They also share insights on personal responsibility against government overreach, recent Idaho legislation, and the ongoing implications for medical freedom and individual rights.

11 snips
Nov 27, 2024 • 1h 2min
Sasha Latypova #998
Sasha Latypova, a retired pharma and medical device R&D executive, shares her insights on the challenges of censorship in discussing vaccine safety. She candidly recounts her experiences being banned on YouTube and explores deep-seated distrust in public health figures regarding mRNA vaccines. The conversation delves into the controversial reevaluation of polio as a toxic rather than viral issue, critiques new cabinet appointments in health agencies, and highlights the importance of independent platforms for sharing critical health information. A thought-provoking listen!

Sep 6, 2025 • 1h 13min
FINALLY: Trump Demands Pfizer Release mRNA Safety Data, Questions Effectiveness of ‘Operation Warp Speed’ Pandemic Response w/ Sasha Latypova & Dr. Chloe Carmichael – Ask Dr. Drew – Ep 526
Sasha Latypova, a retired pharma R&D executive with a vast background in cardiovascular safety, and Dr. Chloe Carmichael, a clinical psychologist and bestselling author, dive into Donald Trump's recent critiques of Operation Warp Speed and mRNA vaccines. They explore concerns over vaccine efficacy and the implications of corporate influences in public health. The guest speakers highlight the need for open dialogue about vaccine safety and individual rights amidst ongoing ethical debates, emphasizing the importance of transparency in healthcare decisions.


